- Previous Close
1,911.00 - Open
1,837.00 - Bid 1,833.00 x --
- Ask 1,848.00 x --
- Day's Range
1,729.00 - 1,856.00 - 52 Week Range
1,002.00 - 2,151.00 - Volume
218,100 - Avg. Volume
59,441 - Market Cap (intraday)
20.247B - Beta (5Y Monthly) --
- PE Ratio (TTM)
24.33 - EPS (TTM)
75.75 - Earnings Date Feb 14, 2025
- Forward Dividend & Yield 28.00 (2.01%)
- Ex-Dividend Date Mar 28, 2025
- 1y Target Est
--
Kusurinomadoguchi, Inc. provides solutions for pharmacies and medical care in Japan. The company offers EPARK drug counter, a pharmacy/drugstore search and reservation site; matching site to buy and sell dead stock medicines at dispensing pharmacies; site for medicine counter telephone medical treatment; Health Tech Navi, an electronic medication history system; Care Daisy system to link recording systems and ICT devices; solution for purchasing pharmaceuticals; and system that allows for centralized management of outpatient reception, outpatient reservations, and online medical treatment. It also provides Pharmacy Support, a customer management system for repeat patients in the pharmacy industry; system specialized for dispensing pharmacies; matching service that connects nursing care facilities and pharmacies; solution from the purchase of pharmaceuticals to the purchase of immovable inventory; Online consultation by hospital support; online medication guidance; support solution to pharmacies; EPARK medicine notebook, a medication notebook that allows to make dispensing reservations and manage family medicines; and a system that allows patients to select the pharmacy they want to visit. The company was founded in 2004 and is headquartered in Tokyo, Japan.
kusurinomadoguchi.co.jp505
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: 5592.T
View MorePerformance Overview: 5592.T
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 5592.T
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 5592.T
View MoreValuation Measures
Market Cap
20.25B
Enterprise Value
10.69B
Trailing P/E
24.35
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.04
Price/Book (mrq)
2.92
Enterprise Value/Revenue
1.08
Enterprise Value/EBITDA
4.13
Financial Highlights
Profitability and Income Statement
Profit Margin
8.78%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
9.2B
Net Income Avi to Common (ttm)
808M
Diluted EPS (ttm)
75.75
Balance Sheet and Cash Flow
Total Cash (mrq)
10.25B
Total Debt/Equity (mrq)
1.50%
Levered Free Cash Flow (ttm)
--